What are the stages, clinical features, diagnosis, and treatment of syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Syphilis: Stages, Clinical Features, Diagnosis, and Treatment

Stages and Clinical Features

Primary Syphilis

Primary syphilis presents with a painless ulcer (chancre) at the infection site, typically accompanied by regional lymphadenopathy. 1

  • The chancre appears as a single painless nodule that rapidly ulcerates at the site of contact 2
  • In HIV-infected persons, multiple or atypical chancres may occur, and primary lesions might be absent or missed 2, 1
  • Regional lymph node swelling is characteristically indolent and associated with the chancre 3
  • The primary stage is highly infectious 4

Secondary Syphilis

Secondary syphilis develops 2-8 weeks after primary inoculation and involves virtually all organ systems. 2

  • Most common manifestations include macular, maculopapular, papulosquamous, or pustular skin lesions that begin on the trunk and spread peripherally, characteristically involving palms and soles 2
  • Generalized lymphadenopathy accompanies the rash 2
  • Constitutional symptoms include fever, malaise, anorexia, arthralgias, and headache 2
  • Condylomata lata (moist, flat papular lesions in warm intertriginous regions) may resemble papillomavirus infection 2
  • Mucous patches in the oral cavity and specific angina are prominent signs 3
  • Secondary syphilis can mimic acute primary HIV infection with constitutional symptoms and CSF abnormalities 2, 1
  • This stage is highly infectious 4
  • Symptoms persist from days to several weeks before resolving 2

Latent Syphilis

Latent syphilis is characterized by positive serologic tests without clinical manifestations. 1

  • Early latent syphilis is defined as infection acquired within the preceding 12 months 2
  • Late latent syphilis refers to infection acquired more than 1 year previously 2
  • Relapse of secondary manifestations may occur, most commonly during the first 1-4 years following infection 2

Tertiary (Late) Syphilis

Tertiary syphilis occurs in approximately 25% of untreated patients after 3-12 years of latency. 1

  • Gummatous syphilis: Granulomatous lesions (gummas) can affect skin, bones, and other organs 2, 3
  • Cardiovascular syphilis: Inflammatory lesions of the cardiovascular system 2
  • Neurosyphilis: Can occur at any stage but is a hallmark of late disease 2
  • Late manifestations typically become clinically apparent 15-30 years after untreated infection 2

Neurosyphilis

Neurosyphilis can occur at any stage of syphilis and requires specific diagnostic evaluation. 2

  • Asymptomatic neurosyphilis: CSF abnormalities (elevated protein, lymphocytic pleocytosis, or positive VDRL-CSF) without symptoms 2
  • Symptomatic neurosyphilis: Manifestations include meningitis, meningovascular disease, parenchymatous disease, concomitant uveitis, cranial nerve palsies, and optic neuropathies 2, 5
  • HIV-infected persons may have more common manifestations such as concomitant uveitis and meningitis 2

Diagnosis

Direct Detection Methods

Darkfield examination and direct fluorescent antibody tests of lesion exudate or tissue are the definitive methods for diagnosing early syphilis. 2, 1

  • These methods provide direct visualization of Treponema pallidum 2
  • HIV infection does not decrease the sensitivity or specificity of darkfield microscopy 2
  • Biopsy with silver stain can also demonstrate organisms 2

Serologic Testing

Diagnosis requires both nontreponemal and treponemal serologic tests; using only one type is insufficient. 2

Nontreponemal Tests

  • Include VDRL (Venereal Disease Research Laboratory) and RPR (Rapid Plasma Reagin) 2, 1
  • Antibody titers correlate with disease activity and should be reported quantitatively 2
  • A fourfold change in titer (equivalent to two dilutions, e.g., 1:16 to 1:4) is necessary to demonstrate clinically significant difference 2, 1
  • Expected to become nonreactive after treatment, though some patients remain "serofast" at low titers 2
  • False-positive results may occur and must be confirmed with treponemal tests 2

Treponemal Tests

  • Include FTA-ABS (Fluorescent Treponemal Antibody Absorbed) and MHA-TP (Microhemagglutination Assay for Antibody to T. pallidum) 2
  • Most patients remain reactive for life regardless of treatment 2, 1
  • 15-25% of patients treated during primary stage may revert to nonreactive after 2-3 years 2
  • Titers correlate poorly with disease activity and should not be used to assess treatment response 2

Testing Algorithm

  • Traditional approach: Screen with nontreponemal tests, confirm reactive results with treponemal tests 2
  • Some laboratories use reverse algorithm: Screen with treponemal EIA, confirm with nontreponemal testing 2

Neurosyphilis Diagnosis

Neurosyphilis diagnosis requires CSF examination and cannot be made with a single test. 2

  • Reactive VDRL-CSF (RPR is not performed on CSF) is diagnostic when combined with reactive serologic tests 2
  • CSF abnormalities include elevated protein, lymphocytic pleocytosis 2
  • Probable neurosyphilis: Negative VDRL-CSF but elevated CSF protein or leukocyte count with clinical symptoms consistent with neurosyphilis 2

Special Considerations in HIV

  • HIV-infected patients may have atypical serologic responses (unusually high, low, or fluctuating titers) 2
  • Consider additional tests (biopsy, direct microscopy) in HIV patients with abnormal serologic results 2
  • Serologic tests remain accurate and reliable for the vast majority of HIV-infected patients 2
  • All patients with syphilis should be tested for HIV 1, 6

Treatment

Primary and Secondary Syphilis

Benzathine penicillin G 2.4 million units IM as a single dose is the recommended treatment for primary and secondary syphilis. 1, 6

Alternative for Penicillin-Allergic Patients

  • Doxycycline 100 mg orally twice daily for 14 days 1
  • Pregnant women who are penicillin-allergic must be desensitized and treated with penicillin, as it is the only effective option 1

Late Latent Syphilis or Latent Syphilis of Unknown Duration

Benzathine penicillin G 7.2 million units total, administered as three doses of 2.4 million units IM at 1-week intervals. 1, 6

  • Alternative for penicillin-allergic non-pregnant patients: Doxycycline 100 mg orally twice daily for 28 days 1

Neurosyphilis

Aqueous crystalline penicillin G 18-24 million units per day IV (administered as 3-4 million units every 4 hours) for 10-14 days. 1

  • Penicillin-allergic patients with neurosyphilis must be desensitized and treated with penicillin 1
  • All patients with ocular syphilis should be evaluated and treated for neurosyphilis 5

Important Treatment Considerations

  • Penicillin remains the only proven effective treatment for neurosyphilis and syphilis in pregnancy 1
  • Macrolide resistance has emerged, essentially precluding empirical use of azithromycin 4
  • Jarisch-Herxheimer reaction (acute febrile reaction with headache and myalgia) may occur within 24 hours after any therapy for syphilis 1

Follow-Up and Treatment Response

Monitoring

Quantitative nontreponemal tests should be repeated at 3,6,12, and 24 months after treatment. 1

  • A fourfold decline in titer is expected within 6 months for primary/secondary syphilis 1
  • Treatment failure is defined as failure of nontreponemal test titers to decline fourfold within 6 months after therapy for primary or secondary syphilis 1

Special Populations

  • HIV-infected patients may have more apparent clinical lesions and accelerated disease progression 2, 1
  • HIV-positive patients require closer follow-up with repeat quantitative nontreponemal tests 6
  • Early syphilis in HIV-infected persons may cause transient decrease in CD4+ count and increase in HIV viral load that improves with standard treatment 2

Partner Management

All sexual partners exposed within 90 days before diagnosis should be treated presumptively, even if seronegative. 6

  • Partners should be examined, tested, and treated if they had sexual contact during the 30 days preceding onset of symptoms 2

Prevention Strategies

  • Screen sexually active people aged 15-44 years at least once, and at least annually for those at increased risk 7
  • Screen pregnant individuals 3 times: at first prenatal visit, during third trimester, and at delivery 7
  • Counsel about condom use 7
  • Offer doxycycline postexposure prophylaxis (200 mg within 72 hours after sex) to men who have sex with men and transgender women with history of STI in past year 7

References

Guideline

Syphilis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Syphilis. Clinical aspects of Treponema pallidum infection].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2004

Research

Syphilis: Re-emergence of an old foe.

Microbial cell (Graz, Austria), 2016

Research

Ocular manifestations and treatment of syphilis.

Seminars in ophthalmology, 2005

Guideline

Syphilis and Testicular Involvement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Syphilis: A Review.

JAMA, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.